Related Experiment Videos
[Hypertension management in practice, 1986]
Insights
Individuals with persistent high blood pressure should first try non-drug treatments. Antihypertensive medication is advised for emergencies, severe hypertension, or mild cases unresponsive to lifestyle changes, considering cardiovascular risk factors.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Context:
- Hypertension management guidelines emphasize non-pharmacological measures for borderline blood pressure.
- Pharmacological intervention is indicated for specific hypertensive states and risk profiles.
Purpose:
- To outline recommendations for initiating antihypertensive pharmacotherapy.
- To discuss the role of new drug classes and concerns regarding conventional therapies.
Summary:
- Non-pharmacological measures are foundational for elevated blood pressure. Pharmacotherapy is recommended for hypertensive emergencies, diastolic values >100 mm Hg, mild hypertension unresponsive to lifestyle changes, persistent borderline readings with risk factors, and isolated systolic hypertension >180 mm Hg.
- In frail elderly patients, antihypertensive drugs are generally reserved for diastolic pressures consistently above 110 mm Hg.
- Newer agents like calcium channel blockers and ACE inhibitors are now widely used, while thiazide diuretics face scrutiny for potential adverse coronary effects.
Impact:
- Provides clear criteria for the clinical application of antihypertensive medications.
- Highlights the evolving landscape of hypertension treatment, balancing efficacy with potential risks.
- Informs clinical decision-making for optimizing patient outcomes in hypertension management.
Abstract:
Persons with persisting (at least 3 measurements over several weeks) borderline blood pressure elevation or established hypertension should always be instructed to follow general non-pharmacological measures. Antihypertensive pharmacotherapy is recommended in the following situations: in hypertensive emergencies, immediately; if the hypertension is not due to a surgically remediable cause, in patients with documented (at least 3 measurements) blood pressure elevation to diastolic values greater than 100 mm Hg; in patients with "mild" hypertension (diastolic up to 104 mm Hg) which does not decrease to less than 160/95 mm Hg following 3 to 6 months of treatment with general non-pharmacological measures; in persons with borderline blood pressure values (141-159/91-94 mm Hg) that persist following 6 to 12 months of general measures and only if they have severe additional cardiovascular risk factors; in patients with pronounced isolated systolic hypertension (greater than 180 mm Hg). In elderly patients who are frail or have evidence of advanced cardiovascular disease, dementia or other debilitating illnesses, blood pressure-lowering drugs should generally be reserved for diastolic blood pressure values consistently exceeding 110 mm Hg. There have recently been important new developments in antihypertensive pharmacotherapy. Two new pharmacological principles, the calcium entry blockers and angiotensin converting enzyme (ACE) inhibitors, have been introduced widely into practical hypertension treatment. On the other hand, concern has arisen that the conventional, thiazide-diuretic based therapy, despite its established beneficial influence on blood pressure and most cardiovascular complications, may not significantly improve or may sometimes even adversely affect coronary prognosis because of metabolic side effects.(ABSTRACT TRUNCATED AT 400 WORDS)